BioWorld

Jan. 29, 2009

View Archived Issues

Exact to Get $24.5M in Deal with Genzyme

After rejecting a hostile bid by Sequenom Inc., Exact Sciences Corp. has entered a $24.5 million deal with Genzyme Corp. in a move that could help grow Exact's cancer diagnostics business. (BioWorld Today) Read More

Seattle Genetics Braves Public Market to Price $55.8M Offering

Read More

Two Studies Report on Models, Consequences of Hepatitis C

Read More

Gilead has Strong 4Q, but U.S. HIV Drug Sales Down

Read More

Other News To Note

Read More

Clinic Roundup

Read More